Live Breaking News & Updates on Huma Board Director

Stay updated with breaking news from Huma board director. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Huma raises $130 million financing to scale its digital health platform for better care and research


LONDON and NEW YORK
 , May 12, 2021 /PRNewswire/  Huma Therapeutics Limited today announces the completion of its latest funding round with financing of approximately $130 million. The investment will scale Huma s modular platform which can power digital hospitals at home nationally, and support the pharmaceutical and research industries to run the largest ever decentralized clinical trials. Huma s platform combines predictive algorithms, digital biomarkers and real-world data to advance proactive care and research.
Leaps by Bayer and Hitachi Ventures led the Series C funding round, which also saw new strategic and financial investors become shareholders. Samsung Next, Sony Innovation Fund by IGV , Unilever Ventures and HAT Technology & Innovation Fund by HAT, as well as individuals Nikesh Arora (former president of SoftBank) and Michael Diekmann (Chairman of Allianz) are also new shareholders. ....

United Kingdom , City Of , Jonathan Machado , Dan Vahdat , Alan Milburn , Keiji Kojima , Michael Diekmann , Ignazio Castiglioni , Juergen Eckhardt , Gen Tsuchikawa , Claudia Suessmuth Dyckerhoff , Nikesh Arora , Huma Therapeutics , World Economic Forum Global Innovators Community , Innovation Growth Ventures Co Ltd , Daiwa Capital Holdings , Prudential Regulation Authority , United Kingdom Health , University Of Cambridge , Goldman Sachs International , Stanford University Center , Technology Innovation Fund , Sony Innovation Fund , Financial Conduct Authority , Johns Hopkins Bloomberg School Of Public Health , Formative Research ,

Huma raises $130 million to finance its digital health platform – PCR


Huma raises $130 million to finance its digital health platform
5 hours ago
Huma Therapeutics Limited thas raised approximately $130 million to scale its modular platform which can power digital ‘hospitals at home’ nationally, and support the pharmaceutical and research industries to run the largest ever decentralised clinical trials. Huma’s platform combines predictive algorithms, digital biomarkers and real-world data to advance proactive care and research.
Leaps by Bayer and Hitachi Ventures led the Series C funding round, which also saw new strategic and financial investors become shareholders. Samsung Next, Sony Innovation Fund by IGV, Unilever Ventures and HAT Technology & Innovation Fund by HAT, as well as individuals Nikesh Arora (former president of SoftBank) and Michael Diekmann (Chairman of Allianz) are also new shareholders. ....

United Kingdom , Jonathan Machado , Dan Vahdat , Alan Milburn , Keiji Kojima , Michael Diekmann , Gen Tsuchikawa , Claudia Suessmuth Dyckerhoff , Nikesh Arora , Huma Therapeutics , Sony Innovation Fund , Technology Innovation Fund , United Kingdom Health , Goldman Sachs International , Huma Therapeutics Limited , Hitachi Ventures , Unilever Ventures , Innovation Fund , Sachs International , Middle East , United Kingdom Health Secretary , Huma Board Director , Executive Vice President , Smart Life , Senior Investment Director , Samsung Next ,